When a Euploid Embryo Doesn't Make It

There is a specific kind of confusion to this one. You transferred an embryo that tested euploid — the report said "normal" — and you let yourself exhale. Then the pregnancy ended anyway.

If you are reading this in that gap between relief and grief, the first thing worth saying is that a euploid loss is not a sign that you did something wrong, and it is more common than most people are told. The second is that "euploid" answered one question about the embryo. It was never the whole story.

Why a euploid loss feels so confusing

The reason a normal PGT-A result feels like such strong reassurance is that chromosome problems really are the single most common cause of miscarriage. ACOG notes that about half of early pregnancy losses are linked to a missing or extra chromosome in the embryo.

PGT-A is built to flag exactly that — whole-chromosome gains and losses. So a euploid result genuinely lowers the odds that a whole-chromosome problem was the cause. What it cannot do is rule out everything else. If a euploid pregnancy ends, the explanation, when there is one, usually lives outside the chromosome count.

What "euploid" actually checks — and what it can't

It helps to know exactly what PGT-A measures. PGT-A reads the number of chromosomes in a few cells taken from the trophectoderm — the outer part of the early embryo that goes on to form the placenta, not the baby itself. From those few cells, the lab checks whether all 23 chromosome pairs are present in the expected amount.

That design has three blind spots:

• It does not read individual genes, so a single-gene variant that affects development passes through unseen.
• It has a resolution limit, so small missing or extra pieces of chromosome below that threshold may not register.
• It samples only a handful of cells, so it cannot perfectly represent an embryo that is mosaic — a mix of typical and atypical cells.

"Euploid" is a real and useful signal, but it is a chromosome headcount from a small sample, not a full read of the embryo.

None of this means choosing PGT-A was the wrong call. It is a reasonable, widely used test — its use has grown from about 14% of US IVF cycles in 2014 to roughly 60% in recent SART national data, and it remains a large and accepted part of IVF (ASRM, 2024). A euploid result is genuinely good information. It just is not the whole story.

What else can end a euploid pregnancy

When a chromosomally normal pregnancy is lost, clinicians generally think about causes in a few different categories. Not all of them apply to any one person, and many losses never get a clear answer.

• The uterus and implantation environment — fibroids, polyps, scar tissue, or a uterine shape that affects implantation.
• Blood clotting and immune factors — conditions such as antiphospholipid syndrome, which has established links to recurrent loss.
• Hormonal and metabolic factors — thyroid dysfunction and poorly controlled blood sugar, among others.
• The embryo's own genetics beyond chromosome count — single-gene variants that a chromosome screen is not designed to see.
• Limits of the biopsy itself — a result comes from a few cells, so mosaic or localized findings can be missed.
• Chance — sometimes a healthy-appearing pregnancy ends and no cause is ever found. This is real, and it is not a personal failing.

After a single loss

First, what happened was real. This was a pregnancy you were carrying and hoping for, and losing it matters — the grief does not need a complicated cause to be valid. None of what follows is meant to wave that away.

What the evidence can offer is some reassurance about what comes next. A single euploid loss most often does not repeat, and on its own it usually does not mean an extensive workup is needed right away. That is not the same as "just bad luck." It means the odds are genuinely in your favor going forward, and that holding off on a large evaluation after one loss is a reasonable clinical choice, not a dismissal.

It also does not mean you have to stay quiet. A few questions are reasonable to raise with your clinic even after one loss:

• Given my history, is this counted as a single loss or recurrent loss — and what does that change about what you would recommend now?
• Were there any notes about mosaicism, segmental findings, or biopsy quality on the embryo report I should know about?
• Is there anything you would test now versus only if a loss happens again?

For most people after a single loss, the answer to that last question is "wait and see," and that is a legitimate plan rather than a brush-off. The picture changes when loss happens more than once.

After more than one loss

If this is your situation — more than one unexplained loss of a chromosomally normal pregnancy — a genetic cause becomes more worth investigating. This is a newer and still-developing area of research.

In a 2025 genome-sequencing study of 118 families with unexplained recurrent euploid loss, researchers identified a single-gene (monogenic) cause in about one in four — 25.4%, or 30 of 118 families (Aminbeidokhti et al., medRxiv, 2025; preprint). Most of those causes were inherited from one or both parents, which is part of why some couples consider parental genetic screening.

Separately, researchers have studied a set of "maternal-effect" genes — including TUBB8, NLRP7, and PADI6 — that act in the earliest steps of development, such as cell division and the embryo switching on its own genome. Variants in genes like these have been linked to developmental arrest and pregnancy loss.

Two cautions belong right next to those numbers. A genetic finding is not a diagnosis, and it does not predict whether a future transfer will succeed. And much of this research is recent and ongoing — it describes possibilities to discuss with a clinician, not a settled test that explains every loss.

After more than one loss, these are the questions worth bringing to your clinic, in addition to the embryo-report ones above:

• Should we look at uterine, clotting, immune, and hormonal factors as well as genetic ones — and in what order?
• Given more than one euploid loss, is genetic screening of both partners reasonable, and what would a result actually change?
• Would meeting with a genetic counselor help us decide what is worth testing and how to read it?

One more thing belongs here: a genetic screen looks at only one layer. Even when you are investigating a possible genetic cause, the uterine, clotting, immune, and hormonal factors from the list above are usually worth weighing alongside it rather than instead of it.

Where Reticular fits

Reticular is most clearly suited to the situation where loss has happened more than once and you want to look at layers of genetic information a chromosome count does not cover. Its reproductive-gene screening reviews both partners for variants in genes tied to embryo viability and pregnancy loss, and does not require embryo data. For couples who already have sequenced embryos, that screening can be connected to the embryos themselves.

It is not only for people who have already had recurrent losses. If you are a first-time or earlier-stage parent who wants to lower the chance of a pregnancy loss, this screening may be relevant to you too. Be honest with yourself about the limits here: the published research has focused on recurrent loss, especially recurrent euploid loss, so using it earlier is a reasonable extension of that work rather than something studies have directly proven. A clear screen could help, but it cannot promise a healthy pregnancy, and other factors — the uterus, clotting and immune conditions, hormones — still have to be in order.

This is information to weigh with your care team. It is not a diagnosis, and it is not a transfer instruction. For more on what a normal result does and does not cover, see The Limits of a Normal PGT-A Result.

What to do after one loss, and after more than one

A euploid loss is real, and it is allowed to hurt even though the report once said "normal." Euploid meant the chromosome count looked typical. It did not promise a baby, and it did not check everything.

After one loss, the most common honest answer is that it most likely will not repeat, and that holding off on a large workup for now is reasonable rather than dismissive. After more than one, it is reasonable to look deeper — at the uterus, at clotting and immune factors, and increasingly at genetics — with a clinician who can help you decide what is actually worth testing in your case.